Nexafed decongestant thwarts illegal meth makers
Acura Pharmaceuticals Inc. has launched Nexafed, a nasal decongestant with a technology that disrupts the conversion of pseudoephedrine into the dangerous drug methamphetamine. Nexafed uses Acura’s Impede technology, which disrupts the extraction and conversion of pseudoephedrine to methamphetamine.